Belite Bio, Inc. (BLTE)
Belite Bio Market Cap: 5.990B for Jan. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Ocugen, Inc. | 523.14M |
| Ionis Pharmaceuticals, Inc. | 12.55B |
| Ligand Pharmaceuticals, Inc. | 3.871B |
| IDEAYA Biosciences, Inc. | 3.132B |
| Terns Pharmaceuticals, Inc. | 3.295B |
Market Cap Related Metrics
| PEG Ratio | -1.135 |
| Price to Book Value | 21.85 |
| Price | 159.67 |
| Earnings Yield | -1.20% |
| PEGY Ratio | -1.135 |